The healthcare technology sector has shifted from an era of speculative expansion into a phase of capital discipline and operational accountability. Between 2020 and 2023, industry expansion was characterized by aggressive hiring, low-cost capital deployment, fragmented point-solution experimentation, and unvalidated clinical software pilots. Approaching 2027, fundamental macroeconomic shifts and persistent balance-sheet pressures across institutional buyers have altered comm